Abstract

C-type lectins, as types of pattern recognition receptors (PRRs), have crucial roles in innate immunity, and their conserved carbohydrate recognition domain (CRD) is recognized as the binding dominant to pathogen-associated molecular patterns (PAMPs). In this study, a C-type lectin in the scallop Chlamys farreri (lectin B, GenBank No. DQ209290) was heterologously expressed and the recombinant protein (rlectin B) with a molecular mass of approximately 42 kDa was purified. The rlectin B protein could induce the aggregation of Escherichia coli, Vibrio anguillarum and Staphylococcus aureus. Six monoclonal antibodies (mAbs) against rlectin B was developed, among which two mAbs (1A7 and 2B6) could react with the gills, hepatopancreas, adductor muscle, and haemocytes of C. farreri by indirect immunofluorescence assay and bound to proteins with molecular masses of 21, 28, 37, 45, 58, and 70 kDa in western blot assays. Using the two mAbs, C-type lectins protein levels were detected in C. farreri haemocytes after V. anguillarum infection, showing that that lectin levels rapidly increased, peaking at 12 h before gradually decreasing to the control group levels. Furthermore, the FACS results also confirmed that V. anguillarum infection significantly increasing C-type lectins expression in haemocytes. These data suggest that the mAbs can recognize various C-type lectins in C. farreri and are a useful immunological tool for the detection C-type lectins in scallops.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.